Virus-specific effects of disease-modifying therapies on herpesvirus antibody titers in multiple sclerosis
Epstein-Barr virus (EBV) and human herpesvirus 6 (HHV-6) have both been implicated in multiple sclerosis (MS), yet it remains unclear whether disease-modifying therapies (DMTs) shape antiviral humoral responses. We analyzed antiviral IgG titers in MS patients stratified by current DMT (N = 498 for HHV-6A/B, 410 for E...